Table 2.
Variable | DSS 5-year control, % |
DSS P Value |
---|---|---|
Age | ||
> 65 | 51 | 0.13 |
≤ 65 | 63 | |
Tumor Size | ||
> 5 cm | 60 | 0.95 |
≤ 5 cm | 67 | |
De Novo at presentation | ||
Yes | 64 | 0.047 |
No | 55 | |
Histology | ||
Liposarcoma | 71 | 0.60 |
Other | 56 | |
Grade | ||
High | 54 | 0.006 |
Intermediate | 70 | |
Low | 86 | |
Margin Status | ||
Positive/Uncertain | 59 | 0.04 |
Negative | 63 | |
Treatment Plan | ||
Preop RT | 65 | 0.78 |
Postop RT | 51 | |
Radiation Dose | ||
> 50 Gy | 61 | 0.91 |
≤ 50 Gy | 59 | |
IORT | ||
Yes | 63 | 0.78 |
No | 60 | |
Neo or Adj. Chemo | ||
Yes | 66 | 0.61 |
No | 56 | |
Concurrent Chemoradiation | ||
Yes | 47 | 0.34 |
No | 63 |
Abbreviations: DSS, disease specific survival; RT, radiation therapy; IORT, intraoperative radiation therapy; Neo/Adj, neoadjuvant/adjuvant.